Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.suvenpharm.com | |
Market Cap | 16,937.48 Cr. | |
Enterprise Value(EV) | 16,925.81 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 16.96 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 39.22 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 76.03 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 8.75 | Calculated using Price: 665.35 |
Dividend Yield | 0.90 | Period Ending 2023-03 |
No. of Shares Subscribed | 25.46 Cr. | 254,564,956 Shares |
FaceValue | 1 | |
About Suven Pharmaceuticals Ltd. | ||
The company is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry. |
1 Day |
|
-2.19% |
1 Week |
|
+1.27% |
1 Month |
|
+16.72% |
3 Month |
|
+29.65% |
6 Month |
|
+40.02% |
1 Year |
|
+45.84% |
2 Year |
|
+31.21% |
5 Year |
|
|
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 18.92 | 37.80 | 30.47 | 33.52 | 25.21 | |
Return on Capital Employed (%) | 23.87 | 44.55 | 36.19 | 45.92 | 33.41 | |
Return on Assets (%) | 13.39 | 25.50 | 21.52 | 25.62 | 20.18 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 590 | 845 | 1,181 | 1,527 | 1,735 | 1,935 | |
Non Curr. Liab. | 35 | 128 | 74 | 92 | 72 | 72 | |
Curr. Liab. | 191 | 320 | 322 | 348 | 303 | 112 | |
Minority Int. | |||||||
Equity & Liab. | 816 | 1,292 | 1,576 | 1,967 | 2,110 | 2,120 | |
Non Curr. Assets | 393 | 781 | 910 | 702 | 955 | 951 | |
Curr. Assets | 423 | 511 | 667 | 1,265 | 1,155 | 1,169 | |
Misc. Exp. not W/O | |||||||
Total Assets | 816 | 1,292 | 1,576 | 1,967 | 2,110 | 2,120 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 378 | 834 | 1,010 | 1,320 | 1,340 | 1,302 | |
Other Income | 1 | 18 | 14 | 92 | 46 | 55 | |
Total Income | 378 | 852 | 1,024 | 1,413 | 1,387 | 1,357 | |
Total Expenditure | -206 | -449 | -567 | -739 | -766 | -721 | |
PBIDT | 172 | 403 | 457 | 674 | 620 | 636 | |
Interest | -3 | -23 | -12 | -9 | -13 | -5 | |
Depreciation | -12 | -24 | -32 | -39 | -48 | -49 | |
Taxation | -49 | -88 | -105 | -214 | -148 | -150 | |
Exceptional Items | |||||||
PAT | 109 | 269 | 309 | 454 | 411 | 432 | |
Minority Interest | |||||||
Share Associate | 48 | 54 | |||||
Other Related Items | |||||||
Consolidated Net Profit | 109 | 317 | 362 | 454 | 411 | 432 | |
Adjusted EPS | 12 | 14 | 18 | 16 | 17 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 50 | 407 | 383 | 330 | 451 | |
Cash Fr. Inv. | -65 | -413 | -311 | -136 | -195 | |
Cash Fr. Finan. | 26 | 7 | -76 | -156 | -236 | |
Net Change | 11 | 1 | -5 | 37 | 20 | |
Cash & Cash Eqvt | 11 | 12 | 7 | 45 | 65 |
Wed, 06 Dec 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for UTI Mutual Fund |
Thu, 30 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for UTI Mutual Fund |
Thu, 30 Nov 2023
Announcement under Regulation 30 (LODR)-Cessation Resignation of Senior Management Personnel of the Company. |
Fri, 08 Dec 2023 |
|
|
|
|
|